LinkedIn
Specialty
Course Type
Search
Log In
Specialty
Aesthetics Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In
Menu

Ocular Hypertension and Primary Open-Angle Glaucoma: An Update on Treatment Regimens Webinar

By: Jason Bacharach, MD; Murray Fingeret, OD

This course has expired. You can still review the content but course credit is no longer available.

Webinar Credits: 1

There is every indication that innovations in pharmacotherapy will continue to play a crucial role in the clinical management of patients with glaucoma. During this webcast event, experts will discuss the current state of medical management of glaucoma and the various pipeline entities that proffer to increase the odds of helping patients with glaucoma preserve their vision. We will discuss new classes of medications, intriguing research on drug delivery devices, and exciting theories about how we approach treatment that may unveil potential curative strategies

Expiration Date: Monday, December 31, 2018
Release Date: December 2017

Learning Objectives

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Discuss the limitations of current treatment regimens from both mechanism of action and patient compliance.
  • Explain how novel therapeutics differ in their methods of action from commercially available topical medications
  • Evaluate the safety and efficacy of different treatment modalities for ocular hypertension and primary open-angle glaucoma
  • Assess the latest clinical trial data pertaining to new therapies
  • Discuss future developments and direction of therapeutics for managing glaucoma

 

Accreditation and Designation Statement

Accreditation Statement
Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians

Credit Designation Statement
Evolve Medical Education LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Disclosures

Jason Bacharach, MD
North Bay Eye Associates
Sonoma, California

Murray Fingeret, OD
New York Harbor Healthcare System
Brooklyn, New York

Jason Bacharach, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Alcon; Allergan plc and Glaukos Corporation. Grant/Research Support: Aerie Pharmaceuticals, Inc.; Alcon; Allergan plc; Bausch & Lomb Incorporated; Glaukos Corporation; and Ocular Therapeutix, Inc.
Murray Fingeret, OD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Aerie Pharmaceuticals; Alcon, Allergan plc; Carl Zeiss Meditec; and Inotek Pharmaceuticals. Grant/Research Support:  Carl Zeiss Meditec; Heidelberg Engineering; and Topcon Medical Systems.

EDITORIAL SUPPORT DISCLOSURES

Cheryl Cavanaugh, MS, director of operations, Evolve Medical Education LLC, and Michelle Dalton, medical writer, have no real or apparent conflicts of interest to report.

Rishi P. Singh, MD, peer reviewer, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/ Speaker’s Bureau: Alcon; Allergan; Carl Zeiss Meditec; Genentech; Optos; Regeneron Pharmaceuticals; and Shire Plc. Grant/Research Support: Alcon; Apellis Pharmaceuticals; Genentech; and Regeneron Pharmaceuticals.

Disclaimer

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education LLC and Bausch & Lomb Incorporated

Video Resources

BackNext